Conclusion and Results
One month after completing radiotherapy, the patient had a CT re-examination on July 3, 2023, which showed a significant reduction in the lung cancer lesion (see Figure 3,a2, b2,c2,d2) compared to before the radiotherapy (see Figure 3,a1, b1,c1,d1). No significant abnormalities were found in liver and kidney functions or blood analysis. Through the bronchoalveolar lavage fluid test combined with non-tuberculosis mycobacteria detection, the DNA of non-tuberculosis mycobacteria was found to be positive, but no tuberculosis mycobacteria were detected. Based on the consultation instructions from the tuberculosis department’s doctor, the patient’s anti-tuberculosis treatment was effective.
After two cycles, a therapeutic evaluation was conducted, revealing a slight reduction in the lung cancer lesion(see Figures 3 ,a3,b3,c3,d3) compared to before the chemotherapy(see Figure 3,a2, b2,c2,d2).
On December 16th, 2023, The patient completed anti-tuberculosis treatment. The treatment for pulmonary tuberculosis was effective, and no significant abnormalities were found in liver and kidney functions or blood analysis.
On December 26th, 2023, The patients was reexamined for the first time after all treatments finished. CT showed that the lung lesions were significantly smaller than before treatment (Fig 4 A,B), and the DNA of non-tuberculosis mycobacteria and tuberculosis mycobacteria weren’t detected.
In short, after treatments, the patient’s tumor was obviously reduced and stabilized, tuberculosis was cured. Both anti-tuberculosis treatment and Anti-tumor treatment is effective.